Murao, Shuhei
Yoshimura, Jumpei
Umemura, Yutaka
Oda, Jun
Fujimi, Satoshi
Article History
Received: 10 May 2026
Accepted: 31 July 2026
First Online: 5 August 2026
Declarations
Ethics approval and consent to participate: The study was conducted in accordance with the principles of the Declaration of Helsinki and the Japanese Clinical Trials Act (Act No. 16 of April 14, 2017). The protocol was approved by the Institutional Review Board for Clinical Research of Osaka General Medical Center (IRB No. 2022–057). The board waived the requirement for informed consent because of the anonymous nature of the data and because no information on individual patients was obtained.
Competing interests: The authors declare that they have no competing interests.